[
  {
    "ts": null,
    "headline": "Franklin Biotechnology Discovery Fund Q2 2025 Commentary",
    "summary": "Franklin Templetonâs Biotechnology Discovery Fund sees long-term potential despite Q2 losses. Explore how innovation and AI are shaping its outlook.",
    "url": "https://finnhub.io/api/news?id=d61632bb7ac932a66ab21f6c57260f4bb79e88518f44428ce4f279a1392e761e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753997700,
      "headline": "Franklin Biotechnology Discovery Fund Q2 2025 Commentary",
      "id": 136159393,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1408826216/image_1408826216.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Franklin Templetonâs Biotechnology Discovery Fund sees long-term potential despite Q2 losses. Explore how innovation and AI are shaping its outlook.",
      "url": "https://finnhub.io/api/news?id=d61632bb7ac932a66ab21f6c57260f4bb79e88518f44428ce4f279a1392e761e"
    }
  },
  {
    "ts": null,
    "headline": "Trump Talks Tough on Drug Prices but His Demands Have Softened",
    "summary": "The president threatened to “deploy every tool” in the administration’s arsenal if drug companies don’t cut certain prices by late September.",
    "url": "https://finnhub.io/api/news?id=abfd0cbc3bdf5cf7eec493e57c4c23222429aa6d3fbd91ae1cf65b8720b77b7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753997100,
      "headline": "Trump Talks Tough on Drug Prices but His Demands Have Softened",
      "id": 136160929,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "The president threatened to “deploy every tool” in the administration’s arsenal if drug companies don’t cut certain prices by late September.",
      "url": "https://finnhub.io/api/news?id=abfd0cbc3bdf5cf7eec493e57c4c23222429aa6d3fbd91ae1cf65b8720b77b7a"
    }
  },
  {
    "ts": null,
    "headline": "What Trump's Big Pharma CEO letters mean for drug pricing power",
    "summary": "President Trump is turning up the heat on Big Pharma, sending letters to 17 major drugmakers demanding lower prices across their entire portfolios. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to explain how the administration is pushing for most-favored-nation pricing and giving companies until September 29 to comply. To watch more expert insights and analysis on the latest market action, check out more Market Domination.",
    "url": "https://finnhub.io/api/news?id=4833e7f299553f7689706923f0de2bea0e4ca660804c1eee2c139edccb399c18",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753992991,
      "headline": "What Trump's Big Pharma CEO letters mean for drug pricing power",
      "id": 136160870,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "President Trump is turning up the heat on Big Pharma, sending letters to 17 major drugmakers demanding lower prices across their entire portfolios. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to explain how the administration is pushing for most-favored-nation pricing and giving companies until September 29 to comply. To watch more expert insights and analysis on the latest market action, check out more Market Domination.",
      "url": "https://finnhub.io/api/news?id=4833e7f299553f7689706923f0de2bea0e4ca660804c1eee2c139edccb399c18"
    }
  },
  {
    "ts": null,
    "headline": "Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs",
    "summary": "President Trump sent letters to 17 pharmaceutical companies on Thursday asking them to lower costs of drugs for U.S. consumers to the lowest price offered in other developed nations, following up on an executive order issued in May.",
    "url": "https://finnhub.io/api/news?id=6c9fe155402ddc330d8fc8a3f0a9c10084ffc5e5c1b09cdba3c34ed81efc1a64",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753986626,
      "headline": "Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs",
      "id": 136160873,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "President Trump sent letters to 17 pharmaceutical companies on Thursday asking them to lower costs of drugs for U.S. consumers to the lowest price offered in other developed nations, following up on an executive order issued in May.",
      "url": "https://finnhub.io/api/news?id=6c9fe155402ddc330d8fc8a3f0a9c10084ffc5e5c1b09cdba3c34ed81efc1a64"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=e5ff612bd1bf1306081b26920d3be005c7007c5ecbb5cc0b5b1efb6566b48480",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753979760,
      "headline": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors",
      "id": 136169575,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=e5ff612bd1bf1306081b26920d3be005c7007c5ecbb5cc0b5b1efb6566b48480"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences (GILD) Expected to Beat Earnings Estimates: Should You Buy?",
    "summary": "Gilead (GILD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=c335f32ecf2800debedef56c5b59bfba885ac3893432416029845adc9fa487dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753970407,
      "headline": "Gilead Sciences (GILD) Expected to Beat Earnings Estimates: Should You Buy?",
      "id": 136155226,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead (GILD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=c335f32ecf2800debedef56c5b59bfba885ac3893432416029845adc9fa487dd"
    }
  },
  {
    "ts": null,
    "headline": "Are Wall Street Analysts Bullish on Gilead Sciences Stock?",
    "summary": "Gilead Sciences has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=5c40c3f02514cea3a27c006d8c6c8da4f09b9add41b1771c53ae77b1c326a034",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753969965,
      "headline": "Are Wall Street Analysts Bullish on Gilead Sciences Stock?",
      "id": 136155227,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=5c40c3f02514cea3a27c006d8c6c8da4f09b9add41b1771c53ae77b1c326a034"
    }
  }
]